Lipid lowering explains the insulin sensitivity enhancing effects of a thiazolidinedione, 5-(4-(2-(2-phenyl-4-oxazolyl)ethoxy)benzyl)-2,4 thiazolidinedione*-Reference-Cited by-同舟云学术

Lipid lowering explains the insulin sensitivity enhancing effects of a thiazolidinedione, 5-(4-(2-(2-phenyl-4-oxazolyl)ethoxy)benzyl)-2,4 thiazolidinedione*

Published:2000-05 Issue:3 Volume:2 Page:155-163
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Yakubu-Madus F. E.,Stephens T. W.,Johnson W. T.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1463-1326.2000.00075.x/fullpdf

Reference37 articles.

1. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

2. Mechanism of free fatty acid-induced insulin resistance in humans.

3. Peripheral and hepatic insulin sensitivity in non-insulin-dependent diabetes mellitus: Effect of nonesterified fatty acids

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug;Cardiovascular Diabetology;2021-05-18

2. Association of thiazolidinedione with a lower risk of Parkinson’s disease in a population with newly-diagnosed diabetes mellitus;Annals of Medicine;2018-07-04

3. Doxorubicin treatment inhibits PPARγ and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models;FEBS Letters;2012-12-07

4. The Novel Hypoglycemic Agent YM440 Improves Hepatic Insulin Resistance in Obese Zucker Fatty Rats;Journal of Pharmacological Sciences;2006

5. Rosiglitazone Improves Myocardial Glucose Uptake in Patients With Type 2 Diabetes and Coronary Artery Disease;Diabetes;2005-09-01